Additionally, mice only express DR5, therefore DR4+ regions also confirm the presence of human PC3 tumor cells.[65] DR5 expression for the combination treatment (25.6%) was similar to the PBS treatment (27.0%), and slightly higher compared to the FUS‐ or TRAIL‐only treatments (Figure 6G), consistent with the single treatment pilot study we performed (not shown). The gene discussed is TNFRSF10B; the disease is neoplasm.